Raj Shrivastava, MD Email Raj Shrivastava
- PROFESSOR | Neurosurgery
- PROFESSOR | Otolaryngology
- Hospital Affiliations
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
Dr. Raj Shrivastava is a board-certified Professor of Neurosurgery and Otolaryngology (ENT) and Vice Chair for Clinical Affairs for the Department of Neurosurgery at the Mount Sinai Health System. He specializes in the diagnosis and treatment of skull base tumors, meningiomas, and pituitary tumors. He has sub-specialty fellowship training in complex skull base surgery that entails the use of minimally invasive technologies consisting of endoscopic, 3D, and stereotactic navigation in order to safely remove difficult and "hard-to-reach" brain tumors. He has been active in the advancement and development of these technologies through clinical research, resulting in several national peer-reviewed publications and awards. Dr. Shrivastava lectures nationally and internationally, often being invited to speak as a guest professor and lecturer.
He is a co-investigator of an NIH-funded study that researches the use of Ultra-High Field 7T MRI mapping of skull base tumors to improve patient outcome and safety. He has been appointed to the editorial board of neurosurgery journals in the sub-specialty area of skull base and endoscopic surgery.
Most importantly, however, Dr. Shrivastava believes that patient-centered care, good clinical outcome and personalized treatment comes first, and this will always be his first priority.
Dr. Shrivastava also serves as Director of the Neurosurgery Residency Program.
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Brain Cyst
- Brain Tumor And Brain Cancer
- Brain Tumors
- Brain, Spine Tumors
- Cerebrospinal Fluid Leak
- Chiari Malformation
- Hemifacial Spasm
- Pituitary Adenoma
- Pituitary Diseases
- Pituitary Tumor
- Sinus Cancer
- Skull Base Tumor/Cancer
- Spinal Cord Tumors
- Stereotactic Radiosurgery
- Suprasellar Tumor
- Trigeminal Neuralgia
- Vestibular Schwannoma
Anatomy, Anti-Tumor Therapy, Bioinformatics, Brain, Brain Imaging, Clinical Genomics, Computer Simulation, Genomics, MRI, Neural Networks, Neuroscience, Pituitary, Robotic Surgery, Systems Neuroscience, Translational Research
BS, MS, Stanford University
MD, University of Pennsylvania
Internship, General Surgery
The Mount Sinai Hospital
The Mount Sinai Hospital
Fellowship, Skull Base Surgery
St. Luke's-Roosevelt Hospital Center
2017, 2019, 2020
New York Magazine Best Doctors
America's Top Surgeon Award
Excellence in Neurosurgical Treatment
Castle Connolly Top Doctors
Regional Top Doctor - Neurological Surgery
US News and World Report Selected Top Doctor-Neurosurgery
Patient's Choice Award - National Award
Outstanding Patient Care in Neurosurgery
Compassionate Physician Award - National Award
Patient's Choice - Vital Health Care Group
Awarded to selected physicians by their patients for compassionate care in tumor treatment
American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation
Outstanding Achievement in Neurosurgical Research - History
Ultra-High Field MRI Tumor Mapping
The BioMedical Engineering and Imaging Institute (BMEII) research group has an NIH funded program that develops newer techniques to accurately map tumors and anatomy using ultra-high field 7T MRI. This will allow for more precise and targeted surgical resections-ultimately for better patient outcomes.
The BioMedical Engineering and Imaging Institute
Endoscopic Skull Base Surgery
The Endoscopic Skull Base Surgery research group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. The team researches unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Shrivastava did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.